Are you involved in developing Equality & Diversity practices for or within a Research Infrastructure? Registrations are open for the RItrain Workshop on Equality, Diversity & Inclusion hosted by EMBL-European Bioinformatics Institute, 29-30 October 2018.
Innovative Global Data-Sharing Platform Vivli Launches with 2,500 Clinical Studies from 15 organizations with data from more than 98 countries across numerous disease areas, including diabetes, Alzheimer’s and malaria, and representing the contributions of more than 1.3 million trial participants
The Executive Masters in Management of Research Infrastructures (EMMRI) is an international management development programme tailored to the specific needs of Research Infrastructures.
Swiss Clinical Trial Organisation have published about impact of clinical trial units on the value of clinical research in Switzerland. Click to access the article.
CZECRIN invites you to the 3rd National Clinical Trials Day in Praha, at the Senat PCR, on 22nd May 2018 from 9:30.
CORBEL just launched its 2nd Open Call:
On May 15, 2018, ECRIN (European Clinical Infrastructure Network) and its scientific partner HECRIN organize the annual International Clinical Trials Day (I
The first CRIGH General Assembly took place in Tokyo on March 7-8th, 2018 (programme and
SGP and SwissPedNet are launching a call for project proposals in paediatric health services research
The National Institute of Health and Medical Research (Institut national de la santé et de la recherche médicale, Inserm) is currently recruiting for the following positions:
HECRIN Receives Funding for Project on ‘Establishing and Internationalizing the Thematic Network for Clinical Research’
The Hungarian Clinical Research Infrastructure Network (HECRIN), ECRIN’s Hungarian national scientific partner, received 1.5 billion HUF (4.5 million euros) from the Ministry of Education for the project ‘HRDOP-3.6.2-16-2017-00009 - Establishing and Internationalizing the Thematic Network for Cli
New EU Regulation on Medical Devices
The Guideline for good clinical practice E6(R2) Step 5 was adopted by the European Medicines Agency (EMA) on 14 June 2017.